In this article
- What Is Psilocybin?
- The Johns Hopkins Smoking Cessation Study
- New 2026 Clinical Trial Shows Stronger Evidence
- How Could Psilocybin Help People Quit Smoking?
- The Role of Cognitive Behavioral Therapy (CBT)
- What Does the Reddit Community Say?
- Is Psilocybin Therapy Legal?
- Risks and Safety Considerations
- Why This Research Matters
For decades, quitting smoking has remained one of the hardest long-term behavioral changes for millions of people worldwide. Traditional smoking cessation tools like nicotine patches, gums, and prescription medications help some users, but relapse rates remain high. Now, new research around psilocybin-assisted therapy is reshaping the conversation around nicotine addiction treatment.
Recent studies from researchers at suggest that psilocybin, the psychoactive compound found in “magic mushrooms,” may dramatically improve smoking cessation success rates when combined with psychotherapy and cognitive behavioral therapy (CBT).
What Is Psilocybin?
Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms. Although it remains a controlled substance in many countries, scientific research into its therapeutic potential has accelerated over the last decade.
Researchers are currently studying psilocybin for conditions including:
- Depression
- Anxiety
- PTSD
- Alcohol addiction
- Tobacco addiction
- End-of-life distress
Unlike traditional psychiatric medications taken daily, psilocybin therapy generally involves one or a few guided sessions combined with structured psychotherapy.
The Johns Hopkins Smoking Cessation Study
One of the most influential early studies on psilocybin and smoking cessation came from researchers at. In the pilot study, smokers participated in cognitive behavioral therapy while also receiving two to three guided psilocybin sessions.
The results surprised researchers.
Twelve out of fifteen participants successfully quit smoking for at least six months after treatment, producing an 80% abstinence rate.
Long-term follow-up research later suggested that many participants maintained smoking abstinence years after treatment.
New 2026 Clinical Trial Shows Stronger Evidence
In 2026, researchers published a randomized clinical trial comparing psilocybin-assisted therapy against nicotine patches. The study found that participants receiving psilocybin with CBT had significantly higher long-term abstinence rates than participants using nicotine patches with the same therapeutic support.
According to the published findings in JAMA Network Open, psilocybin-assisted treatment substantially outperformed standard nicotine replacement therapy in helping smokers quit long term.
Researchers concluded that psilocybin represents a promising candidate for future FDA-approved smoking cessation therapies.
How Could Psilocybin Help People Quit Smoking?
Scientists believe psilocybin may work differently from traditional addiction treatments.
Rather than simply reducing cravings, psychedelic-assisted therapy may help users fundamentally re-evaluate their relationship with smoking. Researchers observed that participants often reported:
- Increased emotional clarity
- Reduced compulsive thinking
- Heightened self-awareness
- Strong feelings of personal meaning
- Spiritual or “mystical” experiences
- Greater confidence in their ability to quit
One study specifically found that participants who experienced stronger mystical-type experiences during psilocybin sessions were more likely to remain smoke-free.
The Role of Cognitive Behavioral Therapy (CBT)
Importantly, the studies did not use psilocybin alone.
Participants also underwent structured cognitive behavioral therapy designed specifically for smoking cessation. CBT helps smokers identify triggers, manage cravings, and change behavioral patterns associated with nicotine addiction.
Researchers emphasize that the therapeutic environment, psychological preparation, and post-session integration appear to be critical parts of the process.
What Does the Reddit Community Say?
Beyond clinical research, anecdotal reports from online communities also suggest that some individuals experience reduced nicotine cravings after psychedelic experiences. However, experiences vary widely, and self-reports should not be considered scientific evidence.
“I quit over 2 years ago now, the day after a trip. I didn’t do it to quit nicotine, wasn’t even planning on stopping at that point, but I was so disgusted at the thought of inhaling poison that I threw it away.”View Discussion →
“I definitely find I dislike the taste of cigarettes for a couple of days after, so maybe there’s something to it.”View Discussion →
I quit over 2 years ago now, the day after a trip. I didnt do it to quit nicotine, wasnt even planning on stopping at that point, but I was so disgusted at the thought of inhaling poison that I threw it away.
Not every experience is positive or successful. Some Reddit users also reported increased cigarette cravings during psychedelic experiences, highlighting the complexity of addiction and individual psychology.
Is Psilocybin Therapy Legal?
The legal status of psilocybin varies significantly depending on the country and region.
In most places, psilocybin remains illegal outside of approved research or medical programs. However, several jurisdictions have begun decriminalizing or regulating psychedelic-assisted therapies.
Clinical research is expanding rapidly, particularly in the United States and parts of Europe.
Risks and Safety Considerations
Psilocybin is not risk-free.
Potential risks may include:
- Anxiety or panic during sessions
- Psychological distress
- Confusion
- Temporary paranoia
- Risk of unsafe behavior in uncontrolled settings
People with certain psychiatric conditions, including psychotic disorders, may face elevated risks.
Researchers strongly advise against self-medicating with psychedelics outside professional or clinical environments.
Why This Research Matters
Smoking remains one of the leading causes of preventable death globally. Even with modern cessation tools, many smokers struggle through repeated relapse cycles.
If future large-scale studies confirm current findings, psilocybin-assisted therapy could represent a major breakthrough in addiction treatment. Rather than merely suppressing cravings, psychedelic therapy may help address the deeper psychological patterns driving nicotine dependence.
The research is still evolving, but early evidence suggests the future of smoking cessation may look very different from the nicotine patch era. ![]()
The article is based on the work of Sergio Lázaro Martínez in the Open Foundation